Dienogest Adco 2mg Tablet
PDF Leaflet Revision Date: 28 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of endometriosis.
Dosage (summary)
1 tablet daily, starting on day 1 of menstrual cycle, without breaks.
Special Populations
- Adolescents
- Women with hypertension
- Diabetic women
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- CYP3A4 inducers (e.g., rifampicin)
- CYP3A4 inhibitors (e.g., ketoconazole)
Contraindications
- Hypersensitivity to dienogest
- Known or suspected pregnancy
- Lactation
- History of venous thromboembolic disorder
- Arterial and cardiovascular diseases
- Severe hepatic disease
- Sex hormone-dependent malignancies
- Undiagnosed vaginal bleeding
Common side effects
- Headache
- Breast discomfort
- Depressed mood
- Acne
Counselling Points
- Take at the same time daily
- Use non-hormonal contraception if needed
- Monitor for signs of thrombotic events
Serious warnings
- Risk of thromboembolism
- Changes in bleeding pattern
- Potential decrease in bone mineral density
On This Page
Connecting to Document Server
Decrypting and optimizing pharmaceutical leaflet...
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
